Somnomed Ltd
ASX:SOM
Somnomed Ltd
EPS (Diluted)
Somnomed Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Cochlear Ltd
ASX:COH
|
EPS (Diluted)
AU$5
|
CAGR 3-Years
13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Somnomed Ltd
Glance View
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.
See Also
What is Somnomed Ltd's EPS (Diluted)?
EPS (Diluted)
-0
AUD
Based on the financial report for Dec 31, 2024, Somnomed Ltd's EPS (Diluted) amounts to -0 AUD.
What is Somnomed Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
8%
Over the last year, the EPS (Diluted) growth was 78%. The average annual EPS (Diluted) growth rates for Somnomed Ltd have been 26% over the past three years , 8% over the past five years .
You don't have any saved screeners yet